Sublethal Simulated Ischemia Promotes Delayed Resistance Against Ischemia via ATP-Sensitive (K+) Channels in Murine Myocytes: Role of PKC and iNOS

Antioxidants and Redox Signaling

Volumn 6, Issue 2, 2004, Pages 375-383

  Nayeem, Mohammed A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE; CHELERYTHRINE; GLIBENCLAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; METHYLTHIOUREA; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN KINASE C; PROTEIN KINASE C EPSILON; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REVIEW; SIMULATION; SUBLETHAL SIMULATED ISCHEMIA; SUSTAINED SIMULATED ISCHEMIA;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CELLS, CULTURED; DECANOIC ACIDS; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYBURIDE; HYDROXY ACIDS; ISCHEMIC PRECONDITIONING; ISOTHIURONIUM; L-LACTATE DEHYDROGENASE; MALE; MICE; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; RECEPTOR, ADENOSINE A1;

ANIMALIA; MURINAE;

EID: 1542619263     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308604322899440     Document Type: Review

References (37)

1. Ashcroft SJH and Ashcroft FM. The sulfonylurea receptor. Biochim Biophys Acta 1175: 45-59, 1992.
2. Auchampach JA, Grover GJ, and Gross GJ. Blockade of ischaemic preconditioning in dogs by the novel ATP-dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 26: 1052-1062, 1992.
3. + channels mediate the delayed cardioprotective effect of adenosine Al receptor activation. JMol Cell Cardiol 31: 981-989, 1999.
4. Baxter GF, Marber MS, Patel VC, and Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90: 2993-3000, 1994.
5. Baxter GF, Goma FM, and Yellon DM. Involvement of protein kinase C in delayed cytoprotection following sublethal ischemia in rabbit myocardium. Br J Pharmacol 115: 222-224, 1995.
6. Baxter GF, Mocanu MM, and Yellon DM. Attenuation of myocardial ischemic injury 24 hours after diacylglycerol treatment in vivo. J Mol Cell Cardiol 29: 1967-1975, 1997.
7. Belle HV, Goossens F, and Wynants J. Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am J Physiol 252: H886-H893, 1987.
8. + channels in rabbit heart. Am J Physiol 277: H128-H135, 1999.
9. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, and Jadoon AK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 81: 1094-1107, 1997.
10. Cohen MY, Liu GS, and Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 84: 341-349, 1991.
11. Deutsch E, Berger M, Kussmaul WG, Hirschfeld JW Jr, Hermann HC, and Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation 82: 2044-2051, 1990.
12. Downey JM, Liu GS, and Thorton JD. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res 27: 3-8, 1993.
13. Gerwins P and Fredholm BB. Activation of adenosine A1 and bradykinin receptors increase protein kinase C and phospholipase D activity in smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol 351: 186-193, 1995.
14. Gross GJ and Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70: 223-233, 1992.
15. Gross GJ and Auchampach JA. Role of ATP-dependent potassium channels in myocardial ischaemia. Cardiovasc Res 28: 1011-1016, 1994.
16. Guo Y, Jones WK, Xuan Y-T, Tang X-L, Bao W, Wu W-J, Han H, Laubach VE, Ping P, Yang Z, Qui Y, and Bolli R. The late phase ischemic preconditioning is abrogated by targeted disruption of iNOS gene. Proc NatAcad Sci U S A 96: 11507-11512, 1999.
17. Headrick JP. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol 28: 1227-1240, 1996.
18. Imagawa J, Yellon DM, and Baxter GF. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Br J Pharmacol 126: 701-708, 1999.
19. 1,-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation 91: 2226-2234, 1995.
20. Komamura K, Ito H, Takiuchi S, Iwakura K, Maruyama A, Masuyama T, Minamino T, Node K, Kitakaze M, and Hori M. Transient intracoronary infusion of ATP after reperfusion reduces the extent of no-reflow and infarct size in dogs. J Am Coll Cardiol, 227A, 1995, abstract.
21. Lawson CS and Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 27: 542-550, 1993.
22. Liu GS, Thorton JD, Van Winkle DM, Stanely AWH, Olsson RA, and Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
23. Liu Y and Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 263: H1107-H1112, 1992.
24. 1 adenosine receptor overexpression increases myocardial resistance to ischernia. Proc Nat Acad Sci U S A 94: 6541-6546, 1997.
25. Merkus D, Stepp DW, Jones DW, Nishikawa Y, and Chilian WM. Adenosine precondition against endothelial-induced constriction of coronary arterioles. Am J Physiol Heart Circ Physiol 279: H2593-H2597, 2000.
26. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
27. Nayeem MA, Elliott GT, Shah MR, Hastillo-Hess SL, and Kukreja RC. Monophosphoryl lipid A protects adult rat cardiac myocytes with induction of the 72-kD heat shock protein: a cellular model of pharmacologic preconditioning. J Mol Cell Cardiol 29: 2305-2310, 1997.
28. Nayeem MA, Hess ML, Qian Y, Loesser KE, and Kukreja RC. Delayed preconditioning of cultured adult rat cardiac myocytes: role of 70 and 90 kD heat stress proteins in protection against lethal cellular injury. Am J Physiol 42: H861-H868, 1997.
29. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, and Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997.
30. Qiu Y, Ping P, Tang X-L, Manchikalapudi S, Rizvi A, Zang J, Takano H, Wu W-J, Teschner S, and Bolli R. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that ε is the isoform involved J Clin Invest 101: 2182-2198, 1998.
31. ATP channels in vascular smooth muscle. Cardiovasc Res 28: 797-804, 1994.
32. Reimer KA, Murry CE, Yamasawa I, Hill ML, and Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 251: H1306-H1315, 1986.
33. Schutz W, Schrader J, and Gerlach E. Different sites of adenosine formation in the heart. Am J Physiol 240: H963-H970, 1981.
34. Smolenski RT, Schrader J, De Groot H, and Dessen A. Oxygen partial pressure and free intracellular adenosine of isolated cardiomyocytes. Am J Physiol 260: C708-C714, 1991.
35. + channel blocker. Circulation 90: 700-705, 1994.
36. Yellon DM, Alkhulaifi AM, and Pugsley WB. Preconditioning the human myocardium. Lancet 432: 276-277, 1993.
37. Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G, and Sumeray MS. Ischaemic preconditioning: Present position and future directions. Cardiovasc Res 37: 21-33, 1998.